IRADIMED CORPORATION (IRMD) Cash Flow Statement
IRADIMED CORPORATION (IRMD) generated $27.1M of operating cash flow over the twelve months to 2026-06-30, spent $2.7M on capital expenditure and had free cash flow of $24.5M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
IRMDIRADIMED CORPORATIONFollow IRMD — free
—
Price chart with a free account
- Market cap
- 1.1B
- P/E TTM
- 47.9
- Dividend yield
- 0.9%
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.6 | 7.6 | 9.4 | 3.4 | 7.4 | 10.2 | 5.8 | 11.3 | 10.0 | 13.5 | 25.6 | 24.9 | 27.1 | |
| Capital expenditure | 0.6 | 0.3 | 1.5 | 0.8 | 0.3 | 0.5 | 0.6 | 0.7 | 1.9 | 8.0 | 8.8 | 8.4 | -2.7 | |
| Free cash flow | 2.0 | 7.3 | 7.9 | 2.6 | 7.1 | 9.7 | 5.2 | 10.5 | 8.2 | 5.5 | 16.8 | 16.5 | 24.5 | |
| Dividends paid | — | — | — | — | — | — | — | — | 12.6 | 13.2 | 13.7 | 15.0 | — | |
| Share repurchases | — | — | 10.0 | 1.8 | — | — | — | — | — | — | — | — | — | |
| Stock-based compensation | 0.7 | 1.2 | 1.8 | 2.5 | 1.8 | 1.9 | 4.0 | 1.5 | 1.4 | 2.2 | 2.5 | 2.9 | — |
USD millions · SEC XBRL
IRADIMED CORPORATION — questions
- What is IRADIMED CORPORATION's operating cash flow?
- $27.1M over the twelve months to 2026-06-30.
- How much does IRADIMED CORPORATION spend on capital expenditure?
- $2.7M over the twelve months to 2026-06-30.
- What is IRADIMED CORPORATION's free cash flow?
- $24.5M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from IRADIMED CORPORATION's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.